187 related articles for article (PubMed ID: 21450573)
1. Effects of carvedilol on oxygen uptake and heart rate kinetics in patients with chronic heart failure at simulated altitude.
Karsten M; Contini M; Cefalù C; Cattadori G; Palermo P; Apostolo A; Bussotti M; Magrì D; Salvioni E; Farina S; Sciomer S; Catai AM; Agostoni P
Eur J Prev Cardiol; 2012 Jun; 19(3):444-51. PubMed ID: 21450573
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia.
Agostoni P; Contini M; Magini A; Apostolo A; Cattadori G; Bussotti M; Veglia F; Andreini D; Palermo P
Eur J Heart Fail; 2006 Nov; 8(7):729-35. PubMed ID: 16533619
[TBL] [Abstract][Full Text] [Related]
3. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.
Valentini M; Revera M; Bilo G; Caldara G; Savia G; Styczkiewicz K; Parati S; Gregorini F; Faini A; Branzi G; Malfatto G; Magrì D; Agostoni P; Parati G
Cardiovasc Ther; 2012 Aug; 30(4):240-8. PubMed ID: 21883997
[TBL] [Abstract][Full Text] [Related]
4. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
6. Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol.
Corrà U; Mezzani A; Bosimini E; Scapellato F; Temporelli PL; Eleuteri E; Giannuzzi P
Am Heart J; 2004 Mar; 147(3):553-60. PubMed ID: 14999209
[TBL] [Abstract][Full Text] [Related]
7. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
De Vecchis R; Pucciarelli G; Setaro A; Nocerino L
Minerva Cardioangiol; 2000 Nov; 48(11):393-410. PubMed ID: 11214431
[TBL] [Abstract][Full Text] [Related]
8. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
10. Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients.
Carvalho VO; Guimarães GV; Ciolac EG; Bocchi EA
Clinics (Sao Paulo); 2008 Aug; 63(4):479-82. PubMed ID: 18719758
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-blockers on ventilation efficiency in heart failure.
Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M
Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721
[TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
Castro P; Vukasovic JL; Chiong M; Díaz-Araya G; Alcaino H; Copaja M; Valenzuela R; Greig D; Pérez O; Corbalan R; Lavandero S
Eur J Heart Fail; 2005 Oct; 7(6):1033-9. PubMed ID: 16227141
[TBL] [Abstract][Full Text] [Related]
14. Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
Racine N; Blanchet M; Ducharme A; Marquis J; Boucher JM; Juneau M; White M
J Card Fail; 2003 Aug; 9(4):296-302. PubMed ID: 13680550
[TBL] [Abstract][Full Text] [Related]
15. Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy: heart rate dynamic during exercise test.
Carvalho VO; Rodrigues Alves RX; Bocchi EA; Guimarães GV
Int J Cardiol; 2010 Jun; 142(1):101-4. PubMed ID: 19155077
[TBL] [Abstract][Full Text] [Related]
16. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.
Fraga R; Franco FG; Roveda F; de Matos LN; Braga AM; Rondon MU; Rotta DR; Brum PC; Barretto AC; Middlekauff HR; Negrão CE
Eur J Heart Fail; 2007; 9(6-7):630-6. PubMed ID: 17475552
[TBL] [Abstract][Full Text] [Related]
17. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude.
Bilo G; Caldara G; Styczkiewicz K; Revera M; Lombardi C; Giglio A; Zambon A; Corrao G; Faini A; Valentini M; Mancia G; Parati G
J Hypertens; 2011 Feb; 29(2):380-7. PubMed ID: 21045724
[TBL] [Abstract][Full Text] [Related]
19. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
[TBL] [Abstract][Full Text] [Related]
20. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
